Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS)-Reference-Cited by-同舟云学术

Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS)

Published:2022-07 Issue:7 Volume:33 Page:720-727
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Zer A.,Icht O.,Yosef L.,Avram D.,Jacobi O.,Fenig E.,Kurman N.,Peretz I.,Shamai S.,Merimsky O.,Ben-Ami E.,Shapira Frommer R.,Schwarzbach A.E.,Bernstine H.,Weitzen R.,Vornicova O.,Bar-Sela G.,Stemmer S.M.,Lotem M.

Funder

Bristol-Myers Squibb

Merck Sharp and Dohme

AstraZeneca

Paul Scherrer Institut

Merck

Novartis

Takeda Pharmaceutical Company

Roche

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference29 articles.

1. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma;Chang;Science,1994

2. Epidemiological characteristics of Kaposi’s sarcoma prior to the AIDS epidemic;Kaldor;Br J Cancer,1994

3. Sarcoma incidence and subtype distribution in Israel - A population-based study;Icht;Cancer Epidemiol,2020

4. Tailoring treatment for classical Kaposi’s sarcoma: comprehensive clinical guidelines;Brenner;Int J Oncol,1999

5. Highly active antiretroviral therapy in AIDS-associated Kaposi’s sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi’s sarcoma;Krown;J Clin Oncol,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps;Circulation Research;2024-05-24

2. Role of Immunotherapy in Sarcomas;International Journal of Molecular Sciences;2024-01-19

3. MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama;BMC Cancer;2023-06-06

4. Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?;Journal of Medical Virology;2023-05

5. Emerging predictive biomarkers in the management of bone and soft tissue sarcomas;Expert Review of Anticancer Therapy;2023-04-10